Lv3
328 积分 2025-04-14 加入
Cardiovascular and Hepatic Outcomes: Prognostic Differences Across MASLD-MetALD-ALD Continuum
20天前
已关闭
Revisiting the Obesity Paradox in Metabolic Dysfunction-associated Steatotic Liver Disease: Longitudinal Trajectory Analysis Reveals Time-varying Mortality Risks
1个月前
已完结
Cardiovascular health factors and altered proteomic landscapes in the progression of cardiovascular-kidney-metabolic syndrome: Evidence from multi-cohorts in China, the UK, and the US
1个月前
已完结
Subtype Differences in Major Adverse Liver Outcomes and Cardiovascular Events and Mortality in Steatotic Liver Disease: A UK Biobank Analysis
1个月前
已完结
Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions
1个月前
已完结
Episodic Heavy Drinking and Implications for Steatotic Liver Disease Nomenclature: A National Cross-Sectional Study
2个月前
已完结
Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis
3个月前
已完结
Proteomic signatures of healthy dietary patterns are associated with lower risks of major chronic diseases and mortality
4个月前
已完结
Proteomic signatures of sweetened beverages are associated with higher risk of adverse liver outcomes
5个月前
已完结
Chronic kidney disease onset, progression, and cardiovascular outcomes: proteomics informs biology and risk stratification
5个月前
已完结
皖公网安备34019202002308
